04734nam 2200637 450 991064326370332120230213211705.01-283-57215-X97866138846020-470-71988-50-470-71754-8(CKB)1000000000688099(EBL)703830(OCoLC)811488085(SSID)ssj0000715407(PQKBManifestationID)11404022(PQKBTitleCode)TC0000715407(PQKBWorkID)10703145(PQKB)11368059(MiAaPQ)EBC703830(EXLCZ)99100000000068809920160812h19721972 uy 0engur|n|---|||||txtccrOntogeny of acquired immunity /Ciba FoundationAmsterdam, [Netherlands] ;London, [England] ;New York, New York :Associated Scientific Publishers,1972.©19721 online resource (284 p.)Ciba Foundation SymposiumDescription based upon print version of record.0-470-66293-X 90-219-4005-1 Includes bibliographical references at the end of each chapters and index.Ontogeny of Acquired Immunity; Contents; Contributors; Introduction; 1 What Precedes Clonal Selection?; THE CLONAL SELECTION THEORY; THE ANTIBODY REPERTOIRE; THE AVAILABLE REPERTOIRE; REPERTOIRE SUPPRESSION; SOURCE OF THE REPERTOIRE; BOUNDARY CONDITIONS; References; Discussion; References; 2 Immunological maturation in the foetus: modulation of the pathogenesis of congenital infectious diseases; ONTOGENESIS OF THE IMMUNE RESPONSE; IMMUNOLOGICAL SUPPRESSION OF PATHOGENICITY; THE IMMUNOLOGICAL ACTIVATION OF PATHOGENlClTY; THE IMMUNOLOGICAL MODULATION OF PATHOGENESISIMMUNOLOGICAL TOLERANCE IN CONGENITAL INFECTIONSUMMARY; ACKNOWLEDGEMENTS; References; Discussion; References; 3 The origins and development of lymphocyte populations; EMBRYONIC HAEMOPOIESIS: DEFINITION, DERIVATION, POTENTIALITIES AND NATUREOF STEM CELLS; LYMPHOPOIESlS IN THE CHICK EMBRYO; SUMMARY; References; Discussion; THETA SPECIFICITY; FUNCTIONAL DIFFERENCES AMONG T CELLS; ANTI-RECEPTOR ANTIBODIES; References; 4 Ontogeny of components of complement and lysozyme; COMPLEMENT; LYSOZYME; SUMMARY; ACKNOWLEDGEMENTS; References; Discussion; References; 5 Allotype suppressionALLOTYPE SUPPRESSION IN HETEROZYGOTESALLOTYPE SUPPRESSION IN HOMOZYGOTES; CHARACTERISTICS OF ALLOTYPE SUPPRESSION; SUMMARY; References; Discussion; References; 6 Development of cellular immunocompetence in man; BLASTOGENIC RESPONSE OF FOETAL LYMPHOCYTES TO PHA; PHA-MEDIATED LYMPHOCYTOTOXICITY BY HUMAN FOETAL LYMPHOCYTES; DEVELOPMENT OF THE ROSETTE-FORMING CELL IN THE HUMAN FOETUS; SUMMARY; ACKNOWLEDGEMENTS; References; Discussion; References; 7 The role of serum factors ('blocking antibodies') as mediators of immunological non-reactivity to cellular antigens'BLOCKING ANTIBODIES' TO TUMOUR-ASSOCIATED (SPECIFIC) ANTIGENSEVIDENCE FOR 'BLOCKING ANTIBODIES' IN PREGNANT MICE; BLOCKING SERUM ACTIVITY IN MICE 'TOLERANT' OF ALLOGRAFTS; WHAT IS THE NATURE OF THE BLOCKING FACTORS AND HOW DO THEY ACT?; SUMMARY; ACKNOWLEDGEMENTS; References; Discussion; References; 8 Concerning the uterus as a graft site and the foetus as a natural parabiotic organismic homograft; ANALYSIS OF THE UTERUS AS A GRAFT SITE; STUDIES ON THE IMMUNOLOGICAL CONSEQUENCES OF A PUTATIVE NATURAL MATERNAL-FOETAL TRANSMISSION OF CELLS IN RATS; DISCUSSION; SUMMARY; ACKNOWLEDGEMENTReferencesDiscussion; References; 9 Bone marrow transplantation in a genetically determined anaemia in the mouse; EXPERIMENTS IN NEONATAL MICE; EXPERIMENTS IN ADULT MICE; DISCUSSION; SUMMARY; ACKNOWLEDGEMENTS; References; Discussion; References; 10 Genetic deficiencies of the complement system; GENETIC DEFICIENCIES OF COMPLEMENT COMPONENTS; DEFICIENCY OF COMPLEMENT INHIBITORS; ACKNOWLEDGEMENTS; References; Discussion; References; 11 Defects in immunological development in man; AETIOLOGICAL CONSIDERATIONS; SUMMARY; References; Discussion; References12 Treatment of immune deficiency disease with bone marrow stem cell concentratesCiba Foundation symposium.ImmunityCongressesImmunity616.07/9616.079Ciba Foundation.Symposium on Ontogeny of Acquired ImmunityMiAaPQMiAaPQMiAaPQBOOK9910643263703321Ontogeny of acquired immunity3005017UNINA